Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry.

Willeit M, Praschak-Rieder N.

Neuroimage. 2010 Nov 15;53(3):878-92. doi: 10.1016/j.neuroimage.2010.04.030. Epub 2010 Apr 23. Review.

PMID:
20399868
2.

Genetics of the serotonergic system in suicidal behavior.

Arango V, Huang YY, Underwood MD, Mann JJ.

J Psychiatr Res. 2003 Sep-Oct;37(5):375-86. Review.

PMID:
12849930
3.

Brain radioligands--state of the art and new trends.

Halldin C, Gulyás B, Langer O, Farde L.

Q J Nucl Med. 2001 Jun;45(2):139-52. Review.

PMID:
11476163
4.
5.

Applications of clinical dopamine imaging.

Lindsey KP, Gatley SJ.

Neuroimaging Clin N Am. 2006 Nov;16(4):553-73, vii-viii. Review.

PMID:
17148019
6.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
7.

An introduction to PET and SPECT neuroreceptor quantification models.

Ichise M, Meyer JH, Yonekura Y.

J Nucl Med. 2001 May;42(5):755-63. Review.

8.

Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.

Laruelle M, Huang Y.

Q J Nucl Med. 2001 Jun;45(2):124-38. Review.

PMID:
11476162
9.
10.

Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders.

D'Souza UM, Craig IW.

Prog Brain Res. 2008;172:73-98. doi: 10.1016/S0079-6123(08)00904-7. Review.

PMID:
18772028
11.
12.

Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.

Shiroma PR, Geda YE, Mrazek DA.

Pharmacogenomics. 2010 Sep;11(9):1305-30. doi: 10.2217/pgs.10.118. Review.

PMID:
20860469
13.

Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.

Murphy DL, Uhl GR, Holmes A, Ren-Patterson R, Hall FS, Sora I, Detera-Wadleigh S, Lesch KP.

Genes Brain Behav. 2003 Dec;2(6):350-64. Review.

14.

Imaging neurochemical endophenotypes: promises and pitfalls.

Martinez D, Broft A, Laruelle M.

Pharmacogenomics. 2001 Aug;2(3):223-37. Review.

PMID:
11535111
15.

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.

Oya S, Choi SR, Hou C, Mu M, Kung MP, Acton PD, Siciliano M, Kung HF.

Nucl Med Biol. 2000 Apr;27(3):249-54.

PMID:
10832081
16.

Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope.

Abdolmaleky HM, Thiagalingam S, Wilcox M.

Am J Pharmacogenomics. 2005;5(3):149-60. Review.

PMID:
15952869
17.

Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder.

Hemmings SM, Kinnear CJ, Niehaus DJ, Moolman-Smook JC, Lochner C, Knowles JA, Corfield VA, Stein DJ.

Eur Neuropsychopharmacol. 2003 Mar;13(2):93-8.

PMID:
12650952
18.
19.

Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans.

Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, Eisenberg E.

Pain. 2009 Dec 15;147(1-3):187-93. doi: 10.1016/j.pain.2009.09.001. Epub 2009 Sep 30.

PMID:
19796878
20.

Applications of neuroreceptor imaging to psychiatry research.

Smith GS, Koppel J, Goldberg S.

Psychopharmacol Bull. 2003;37(4):26-65. Review.

PMID:
15131516

Supplemental Content

Support Center